ESBA-555

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameESBA-555
Drug Alias NameVEGF-targeting antibody fragment (ESBAtech)ESBA-3XXESBA-555
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionVascular endothelial growth factor modulators
TargetsVascular endothelial growth factor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEsbatech Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEsbatech Ag
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A